Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Heller

Showing results (71-80 of 246) with videos related to

Pageof 25
Sort By:
Thrombosis and Haemostasis|May 3, 1993
Further studies on the plasma inhibitor of platelet activation in Argentine hemorrhagic feverR F Marta, M V Heller, J I Maiztegui, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 20, 2009
The WOMEN study: what is the optimal method for ischemia evaluation in women? A multi-center, prospective, randomized study to establish the optimal method for detection of coronary artery disease (CAD) risk in women at an intermediate-high pretest likelihood of CAD: study designJennifer H Mieres, Leslee J Shaw, Robert C Hendel, et al.
Pharmacotherapy|July 1, 1997
Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study GroupG V Heller, M Sridharan, J Morse, et al.
American Heart Journal|July 1, 1997
Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS)G V Heller, K A Brown, R J Landin, et al.
Journal of the American College of Cardiology|July 1, 1994
The ischemic threshold does vary under differing exercise conditionsC E Garber, G V Heller, M M Barbour, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 16, 2014
Does risk for major adverse cardiac events in patients undergoing vasodilator stress with adjunctive exercise differ from patients undergoing either standard exercise or vasodilator stress with myocardial perfusion imaging?Sanjeev U Nair, Alan W Ahlberg, Deborah M Katten, et al.
Journal of the American College of Cardiology|May 1, 1991
The threshold for myocardial ischemia varies in patients with coronary artery disease depending on the exercise protocolC E Garber, R A Carleton, D N Camaione, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 20, 2012
Risk stratification of CAD with SPECT-MPI in women with known estrogen statusNitesh Sood, Fawad A Kazi, Justin B Lundbye, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 25, 2013
Risk stratification among diabetic patients undergoing stress myocardial perfusion imagingAbhijit Ghatak, Santosh Padala, Deborah M Katten, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 1, 1997
A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part IIL J Shaw, E L Eisenstein, R Hachamovitch, et al.
Pageof 25

Showing results (71-80 of 246) with videos related to

Sort By:
Pageof 25
Thrombosis and Haemostasis|May 3, 1993
Further studies on the plasma inhibitor of platelet activation in Argentine hemorrhagic feverR F Marta, M V Heller, J I Maiztegui, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 20, 2009
The WOMEN study: what is the optimal method for ischemia evaluation in women? A multi-center, prospective, randomized study to establish the optimal method for detection of coronary artery disease (CAD) risk in women at an intermediate-high pretest likelihood of CAD: study designJennifer H Mieres, Leslee J Shaw, Robert C Hendel, et al.
Pharmacotherapy|July 1, 1997
Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study GroupG V Heller, M Sridharan, J Morse, et al.
American Heart Journal|July 1, 1997
Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS)G V Heller, K A Brown, R J Landin, et al.
Journal of the American College of Cardiology|July 1, 1994
The ischemic threshold does vary under differing exercise conditionsC E Garber, G V Heller, M M Barbour, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 16, 2014
Does risk for major adverse cardiac events in patients undergoing vasodilator stress with adjunctive exercise differ from patients undergoing either standard exercise or vasodilator stress with myocardial perfusion imaging?Sanjeev U Nair, Alan W Ahlberg, Deborah M Katten, et al.
Journal of the American College of Cardiology|May 1, 1991
The threshold for myocardial ischemia varies in patients with coronary artery disease depending on the exercise protocolC E Garber, R A Carleton, D N Camaione, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 20, 2012
Risk stratification of CAD with SPECT-MPI in women with known estrogen statusNitesh Sood, Fawad A Kazi, Justin B Lundbye, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 25, 2013
Risk stratification among diabetic patients undergoing stress myocardial perfusion imagingAbhijit Ghatak, Santosh Padala, Deborah M Katten, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 1, 1997
A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part IIL J Shaw, E L Eisenstein, R Hachamovitch, et al.
Pageof 25